genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Small Molecules
Lilly Making First Milestone Payment in $1.9B Collaboration with AC Immune
News
Microbiome Hungry for the Right Fiber
Neuroscience
This Receptor Actually Leaves a Sour Taste in One’s Mouth
News
A Denisovan as Pretty as an Epigenetic Picture
News
Ginkgo to Expand Applications of Cell Programming Platform with $290M Series…
Insights
Tech Exclusives
8 Companion Diagnostic Developers Making a Mark
Tech Exclusives
CRISPR-Chip Launched as “Genome Sensor”
Bioprocessing
Controlling Impurities in Cell Culture Media
Insights
10 Takeover Targets to Watch This Fall
Tech Exclusives
Going Viral: The Next Generation of AAV Vectors
A-Lists
Insights
10 Takeover Targets to Watch This Fall
Insights
What the Top 10 Biopharma CEOs Are Making
Insights
Top 10 Companies Leveraging Gene Editing in 2019
Insights
Top 10 Young Companies in the Money, January–July 2019
August 2019 Vol. 39 No. 8
Top 10 Biopharma IPOs of January–June 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Small Molecules
Lilly Making First Milestone Payment in $1.9B Collaboration with AC Immune
News
Microbiome Hungry for the Right Fiber
Tech Exclusives
8 Companion Diagnostic Developers Making a Mark
News
A Denisovan as Pretty as an Epigenetic Picture
Magazine
Tech Exclusives
Going Viral: The Next Generation of AAV Vectors
Tech Exclusives
Looking Into a Crystal Ball
Tech Exclusives
Liquid Biopsies Intensify Surveillance of ctDNA
Tech Exclusives
Drug–Drug Interaction Studies Look Beyond CYP Activity
Tech Exclusives
3D Bioprinting Makes the Imitation Matrix Real
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
eBooks
Breakthroughs in Immunotherapy
Upcoming Webinars
Pancreatic Cancer Therapeutic Target Visualized Using In Situ Hybridization
Upcoming Webinars
Bring Greater Efficiency to Your Biobank Lab
Upcoming Webinars
Reliable Single Cell Outgrowth: Dark Art or Science?
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Drug Discovery
Small Molecules
Small Molecules
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Small Molecules
Lilly Making First Milestone Payment in $1.9B Collaboration with AC Immune
Small Molecules
Proteinopathy Cleared Up after Cargo Receptor Made to Give Up Misfolded Protein
Small Molecules
Merck & Co., Skyhawk Collaborate on RNA-Binding Small Molecule Therapies
Small Molecules
Amgen Offers $167M for Cancer Collaboration Partner Nuevolution
Small Molecules
Cellular Stress, Not Infection, May Rouse Slumbering MS-Linked Retroviruses
Small Molecules
Tweaked Beer Hop Compound: Thwarts Cancer, Less Estrogen
Small Molecules
Amgen Selects Second Cancer Target in 2-Year-Old Collaboration with Nuevolution
Small Molecules
Ophthotech Expands Eye Disease Pipelines of Small Molecule, Gene Therapy Candidates
Small Molecules
FDA Approves First Smallpox-Indicated Treatment, SIGA’s TPOXX
Small Molecules
Antibiotic-Antigen Conjugates Bring Immunotherapy to Deadly Bacteria
Small Molecules
Approved Anti-Cancer Drugs Reveal New Target: Non-Coding RNAs
Small Molecules
Aggressive Lymphoma Linked with JAK Inhibitor Use
Small Molecules
Amgen, MD Anderson Launch Two Cancer Collaborations
Small Molecules
For Breast Cancer, Targeting Mitochondria Could Be Key
Small Molecules
Roivant’s Newest Company to Develop Ligand’s Diabetes Candidate LGD-6972
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
